Published in Clin J Am Soc Nephrol on January 01, 2010
Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res (2011) 2.56
Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes Care (2013) 1.99
Integrated multiomics approach identifies calcium and integrin-binding protein-2 as a novel gene for pulse wave velocity. J Hypertens (2016) 1.41
Mechanisms and clinical consequences of vascular calcification. Front Endocrinol (Lausanne) (2012) 1.01
Calcium intake is not associated with increased coronary artery calcification: the Framingham Study. Am J Clin Nutr (2012) 0.96
Molecular Mechanisms of Vascular Calcification in Chronic Kidney Disease: The Link between Bone and the Vasculature. Curr Osteoporos Rep (2015) 0.84
Is excess calcium harmful to health? Nutrients (2010) 0.81
Nutritional strategies for skeletal and cardiovascular health: hard bones, soft arteries, rather than vice versa. Open Heart (2016) 0.78
Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis. Health Econ Rev (2015) 0.77
Calcitriol Suppression of Parathyroid Hormone Fails to Improve Skeletal Properties in an Animal Model of Chronic Kidney Disease. Am J Nephrol (2016) 0.75
Racial Differences in Association of Serum Calcium with Mortality and Incident Cardio- and Cerebrovascular Events. J Clin Endocrinol Metab (2016) 0.75
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ (2010) 6.37
Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med (2007) 3.27
The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos). Am J Gastroenterol (2012) 2.24
Bone turnover markers in the management of postmenopausal osteoporosis. Clin Biochem (2009) 1.85
Low bone mineral density and fracture burden in postmenopausal women. CMAJ (2007) 1.81
Effective initiation of osteoporosis diagnosis and treatment for patients with a fragility fracture in an orthopaedic environment. J Bone Joint Surg Am (2006) 1.72
The risk of hip fractures in older individuals with diabetes: a population-based study. Diabetes Care (2007) 1.61
Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials. Arch Intern Med (2004) 1.29
Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD. J Bone Miner Res (2009) 1.15
The effect of raloxifene treatment in postmenopausal women with CKD. J Am Soc Nephrol (2008) 1.13
Retracted Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study. Am J Kidney Dis (2009) 1.05
Geographic variation of bone mineral density and selected risk factors for prediction of incident fracture among Canadians 50 and older. Bone (2008) 1.00
Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos). J Clin Endocrinol Metab (2013) 0.99
The presence of both an energy deficiency and estrogen deficiency exacerbate alterations of bone metabolism in exercising women. Bone (2008) 0.99
Bone mineral density predicts fractures in chronic kidney disease. J Bone Miner Res (2015) 0.98
Spine-hip T-score difference predicts major osteoporotic fracture risk independent of FRAX(®): a population-based report from CAMOS. J Clin Densitom (2011) 0.97
Fracture risk in kidney transplant recipients: a systematic review. Transplantation (2013) 0.83
Tests of neuromuscular function are associated with fractures in patients with chronic kidney disease. Nephrol Dial Transplant (2011) 0.82
Fracture Risk Assessment in Chronic Kidney Disease, Prospective Testing Under Real World Environments (FRACTURE): a prospective study. BMC Nephrol (2010) 0.82
Atypical femoral fractures and bone turnover. N Engl J Med (2011) 0.82
Fractures in chronic kidney disease: pursuing the best screening and management. Curr Opin Nephrol Hypertens (2015) 0.80
Can we compare serum sclerostin results obtained with different assays in hemodialysis patients? Int Urol Nephrol (2015) 0.80
Fracture Incidence in Adult Kidney Transplant Recipients. Transplantation (2016) 0.79
Renal safety in patients treated with bisphosphonates for osteoporosis: a review. J Bone Miner Res (2013) 0.78
Determination of bone architecture and strength in men and women with stage 5 chronic kidney disease. Semin Dial (2012) 0.78
Reducing the risk of re-fracture in the dialysis population: is it time to consider therapy with PTH analogues? Semin Dial (2011) 0.77
Determining whether women with osteopenic bone mineral density have low, moderate, or high clinical fracture risk. Menopause (2010) 0.77
Osteoprotegerin and fractures in men and women with chronic kidney disease. J Bone Miner Metab (2014) 0.77
Evidence for impaired skeletal load adaptation among Canadian women with type 2 diabetes mellitus: insight into the BMD and bone fragility paradox. Metabolism (2013) 0.76
Bone kidney interactions. Rev Endocr Metab Disord (2015) 0.76
Nutrition: calcium and vitamin D for extraskeletal health--jury is out. Nat Rev Endocrinol (2012) 0.75
Nitrates and bone turnover (NABT) - trial to select the best nitrate preparation: study protocol for a randomized controlled trial. Trials (2013) 0.75
The interpretation and utility of bone mineral density by dual energy X-ray absorptiometry in chronic kidney disease. Semin Dial (2014) 0.75
Topical nitrates for osteoporosis: a cheap future direction? Maturitas (2011) 0.75
The clinical characteristics of patients with hip fractures in typical locations and atypical femoral fractures. Arch Osteoporos (2014) 0.75
Lasofoxifene in osteoporosis and its place in therapy. Adv Ther (2010) 0.75